Marketing-authorisation holder · Canada
Eli Lilly Canada Inc
187 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
187 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 187
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BASAGLAR100 unit / ml · Solution | Insulin glargine | Canada | Marketed | 2017 |
| BASAGLAR100 unit / ml · Solution | Insulin glargine | Canada | Marketed | 2015 |
| CIALIS20 mg · Tablet | Tadalafil | Canada | Marketed | 2003 |
| CIALIS10 mg · Tablet | Tadalafil | Canada | Marketed | 2003 |
| CIALIS5 mg · Tablet | Tadalafil | Canada | Marketed | 2008 |
| CIALIS2.5 mg · Tablet | Tadalafil | Canada | Marketed | 2008 |
| CYRAMZA10 mg / ml · Solution | Ramucirumab | Canada | Marketed | 2015 |
| EBGLYSS250 mg / 2 ml · Solution | Lebrikizumab | Canada | Marketed | 2024 |
| EBGLYSS250 mg / 2 ml · Solution | Lebrikizumab | Canada | Marketed | 2024 |
| EMGALITY100 mg / ml · Solution | Galcanezumab | Canada | Marketed | 2021 |
| EMGALITY120 mg / ml · Solution | Galcanezumab | Canada | Marketed | 2019 |
| EMGALITY120 mg / ml · Solution | Galcanezumab | Canada | Marketed | 2019 |
| ENTUZITY KWIKPEN500 unit / ml · Solution | Insulin (human) | Canada | Marketed | 2017 |
| HUMALOG100 unit / ml · Solution | Insulin lispro | Canada | Marketed | 2018 |
| HUMALOG100 unit / ml · Solution | Insulin lispro | Canada | Marketed | 1996 |
| HUMALOG 200 UNITS/ML KWIKPEN200 unit / ml · Solution | Insulin lispro | Canada | Marketed | 2015 |
| HUMALOG (CARTRIDGE)100 unit / ml · Solution | Insulin lispro | Canada | Marketed | 1996 |
| HUMALOG (KWIKPEN)100 unit / ml · Solution | Insulin lispro | Canada | Marketed | 2013 |
| HUMALOG MIX 25 (CARTRIDGE)25 unit / ml + 75 unit / ml · Suspension | Insulin lispro, Insulin lispro protamine suspension | Canada | Marketed | 1999 |
| HUMALOG MIX 25 (KWIKPEN)25 unit / ml + 75 unit / ml · Suspension | Insulin lispro, Insulin lispro protamine suspension | Canada | Marketed | 2013 |
| HUMALOG MIX 50 (CARTRIDGE)50 unit / ml + 50 unit / ml · Suspension | Insulin lispro, Insulin lispro protamine suspension | Canada | Marketed | 2007 |
| HUMALOG MIX 50 (KWIKPEN)50 unit / ml + 50 unit / ml · Suspension | Insulin lispro, Insulin lispro protamine suspension | Canada | Marketed | 2014 |
| HUMULIN 30/70 CARTRIDGE30 unit / ml + 70 unit / ml · Suspension | Insulin (human) | Canada | Marketed | 1992 |
| HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)30 unit / ml + 70 unit / ml · Suspension | Insulin (human) | Canada | Marketed | 1989 |
| HUMULIN N100 unit / ml · Suspension | Insulin (human) | Canada | Marketed | 1983 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 187 | 85 | 102 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.